EKF Diagnostics Holdings plc (LON:EKF) Insider Gavin T. Jones Purchases 50,000 Shares

EKF Diagnostics Holdings plc (LON:EKF) insider Gavin T. Jones purchased 50,000 shares of the firm’s stock in a transaction on Tuesday, March 25th. The shares were purchased at an average cost of GBX 22 ($0.28) per share, with a total value of £11,000 ($14,162.48).

EKF Diagnostics Stock Down 1.5 %

EKF opened at GBX 22.90 ($0.29) on Thursday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The company has a market capitalization of £101.78 million, a PE ratio of 21.31 and a beta of 0.57. The stock’s fifty day moving average is GBX 23.23 and its 200-day moving average is GBX 25.85. EKF Diagnostics Holdings plc has a one year low of GBX 18.40 ($0.24) and a one year high of GBX 33.80 ($0.44).

EKF Diagnostics (LON:EKF) last issued its quarterly earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. On average, equities analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.